Short-course antimicrobial therapy for upper respiratory tract infections

Clinical Therapeutics

Volumn 22, Issue 6, 2000, Pages 673-684

  Guay, David R P ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Beta lactams; Cephalosporins; Macrolides; Otitis media; Sinusitis; Tonsillopharyngitis

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; CEFADROXIL; CEFDINIR; CEFIXIME; CEFOTIAM; CEFPODOXIME PROXETIL; CEFTRIAXONE; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; PENICILLIN G;

ADULT; ANTIMICROBIAL THERAPY; CHILD; CONTROLLED STUDY; HUMAN; JAW DISEASE; LONG TERM CARE; OTITIS MEDIA; PHARYNGITIS; REVIEW; SINUSITIS; STREPTOCOCCUS GROUP A; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION;

EID: 0033939412     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(00)90003-1     Document Type: Article

References (62)

1. 1. Denny FW, Wannamaker LW, Brink WR, et al. Prevention of rheumatic fever: Treatment of the preceding streptococcic infection. JAMA. 1950;142:151-153.
2. 2. Wannamaker LW, Rammelkamp CH Jr, Denny FW, et al. Prophylaxis of acute rheumatic fever by treatment of the preceding streptococcal infection with various amounts of depot penicillin. Am J Med. 1951;10:673-695.
3. 3. Pichichero ME, Cohen R. Shortened course of antibiotic therapy for acute otitis media, sinusitis and tonsillopharyngitis. Pediatr Infect Dis J. 1997;16:680-695.
4. 4. Milatovic D. Evaluation of cefadroxil, penicillin, and erythromycin in the treatment of streptococcal tonsillopharyngitis. Pediatr Infect Dis J. 1991;10(10 Suppl):S61-S63.
5. 5. Pichichero ME, Gooch WM, Rodriguez E, et al. Effective short-course treatment of acute group A β-hemolytic streptococcal tonsillopharyngitis. Arch Pediatr Adolesc Med. 1994;148:1053-1060.
6. 6. Aujard Y, Boucot I, Brahimi N, et al. Comparative efficacy and safety of four-day cefuroxime axetil and ten-day penicillin treatment of group A beta-hemolytic streptococcal pharyngitis in children. Pediatr Infect Dis J. 1995;14:295-300.
7. 7. Mehra S, van Moerkerke M, Welck J, et al. Short course therapy with cefuroxime axetil for group A streptococcal tonsillopharyngitis in children. Pediatr Infect Dis J. 1998;17:452-457.
8. 8. Adam D, Hostalek U, Troster K, Cefixime Study Group. 5-Day cefixime therapy for bacterial pharyngitis and/or tonsillitis: Comparison with 10-day penicillin V therapy. Infection. 1995;23(Suppl 2):S83-S86.
9. 9. Tack KJ, Hedrick JA, Rothstein E, et al. A study of 5-day cefdinir treatment for streptococcal pharyngitis in children. Arch Pediatr Adolesc Med. 1997;151:45-49.
10. 10. Dajani AS. Pharyngitis/tonsillitis: European and United States experience with cefpodoxime proxetil. Pediatr Infect Dis J. 1995;14(Suppl 4):S7-S11.
11. 11. Cohen R, Levy C, Doit C, et al. Six-day amoxicillin vs. ten-day penicillin V therapy for group A streptococcal tonsillopharyngitis. Pediatr Infect Dis J. 1996; 15:678-682.
12. 12. Padilla-Raygoza N. Comparison of clarithromycin and azithromycin for treatment of streptococcal tonsillopharyngitis in children. Infect Med. 1998;15(Suppl A):23-27.
13. 13. Hamil J. Multicenter evaluation of azithromycin and penicillin V in the treatment of acute streptococcal pharyngitis and tonsillitis in children. J Antimicrob Chemother. 1993;31(Suppl E):89-94.
14. 14. Pacifico L, Scopetti F, Ranucci A, et al. Comparative efficacy and safety of 3-day azithromycin and 10-day penicillin V treatment of group A beta-hemolytic streptococcal pharyngitis in children. Antimicrob Agents Chemother. 1996;40:1005-1008.
15. 15. Still JG. Management of pediatric patients with group A beta-hemolytic streptococcal pharyngitis: Treatment options. Pediatr Infect Dis J. 1995;14(Suppl 4):S57-S61.
16. 16. Schaad U, Heynen G, Swiss Tonsillopharyngitis Study Group. Evaluation of the efficacy, safety, and toleration of azithromycin vs. penicillin V in the treatment of acute streptococcal tonsillopharyngitis in children: Results of a multicenter, open comparative study. Pediatr Infect Dis J. 1996;15:791-795.
17. 17. Carbon C, Chatelin A, Bingen E, et al. A double-blind randomized trial comparing the efficacy and safety of a 5-day course of cefotiam hexetil with that of a 10-day course of penicillin V in adult patients with pharyngitis caused by group A β-haemolytic streptococci. J Antimicrob Chemother. 1995;35:843-854.
18. 18. Peyramond D, Portier H, Geslin P, et al. 6-Day amoxicillin versus 10-day penicillin V for group A β-haemolytic streptococcal acute tonsillitis in adults: A French multicenter, open-label, randomized study. Scand J Infect Dis. 1996;28:497-501.
19. 19. Hooten TM. A comparison of azithromycin and penicillin V for the treatment of streptococcal pharyngitis. Am J Med. 1991;91(Suppl 3A):23S-26S.
20. 20. Portier H, Chavanet P, Gouyon JB, Guetat F. Five day treatment of pharyngotonsillitis with cefpodoxime proxetil. J Antimicrob Chemother. 1990;26(Suppl E): 79-85.
21. 21. Portier H, Chavanet P, Waldner-Combernoux A, et al. Five versus ten days' treatment of streptococcal pharyngotonsillitis: A randomized controlled trial comparing cefpodoxime proxetil and phenoxymethyl penicillin. Scand J Infect Dis. 1994;26:59-66.
22. 22. Peyramond D, Tigaud S, Bremard-Oury C, Scheimberg A. Multicenter comparative trial of cefixime and phenoxymethylpenicillin for group A beta-hemolytic streptococcal tonsillitis. Curr Ther Res. 1994;55(Suppl A):14-21.
23. 23. Wannamaker LW, Denny FW, Perry WD, et al. The effect of penicillin prophylaxis on streptococcal disease rates and the carrier state. N Engl J Med. 1953;249:1-7.
24. 24. Bernstein SH, Feldman HA, Harper OF Jr, et al. Observations in Air Force recruits of streptococcal diseases and their control with orally administered penicillin. J Lab Clin Med. 1954;44:1-13.
25. 25. Schwartz RH, Wientzen RL Jr, Pedreira F, et al. Penicillin V for group A streptococcal pharyngotonsillitis. JAMA. 1981;246: 1790-1795.
26. 26. Gerber MA, Randolph MF, Chanatry J, et al. Five vs. ten days of penicillin V therapy for streptococcal pharyngitis. Am J Dis Child. 1987;141:224-227.
27. 27. Stromberg A, Schwan A, Cars O. Five versus ten days' treatment of group A streptococcal pharyngotonsillitis: A randomized controlled clinical trial with phenoxymethylpenicillin and cefadroxil. Scand J Infect Dis. 1988;20:37-46.
28. 28. Eichenwald HF, Stool SE, Stroder J, Hildmann H. Acute otitis media with effusion. In: Eichenwald HF, Stroder J, eds. Pediatric Therapy. 3rd ed. St. Louis, Mo: C.V. Mosby; 1993:364-366.
29. 29. Feigin RD, Kline MW, Hyatt SR, Ford KL III. Otitis media. In: Feigin RD, Cherry JD, eds. Textbook of Pediatric Infectious Diseases. 3rd ed. Philadelphia: WB Saunders Co; 1992:174-189.
30. 30. Hoberman A, Paradise JL, Burch DJ, et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin®) for the treatment of otitis media in children. Pediatr Infect Dis J. 1997;16:463-470.
31. 31. Puczynski MS, Stankiewicz JA, O'Keefe JP. Single dose amoxicillin treatment of acute otitis media. Laryngoscope. 1987; 97:16-18.
32. 32. Bain J, Murphy E, Ross F. Acute otitis media: Clinical course among children who received a short course of high dose antibiotic. Br Med J. 1985;291:1243-1246.
33. 33. Chaput de Saintonge DM, Levine DF, Savage IT, et al. Trial of three-day and ten-day courses of amoxycillin in otitis media. Br Med J. 1982;284:1078-1081.
34. 34. Meistrup-Larsen K-I, Sorensen H, Johnson N-J, et al. Two versus seven days' penicillin treatment for acute otitis media. Acta Otolaryngol. 1983;96:99-104.
35. 35. Ingvarsson L, Lundgren K. Penicillin treatment of acute otitis media in children. Acta Otolaryngol. 1982;94:283-287.
36. 36. Kafetzis DA, Astra H, Mitropoulos L. Five-day versus ten-day treatment of acute otitis media with cefprozil. Eur din Microbiol Infect Dis. 1997;16:283-286.
37. 37. Green SM, Rothrock SG. Single-dose intramuscular ceftriaxone for acute otitis media in children. Pediatrics. 1993;91:23-30.
38. 38. Gehanno P, Taillebe M, Denis P, et al. Short-course cefotaxime compared with five-day co-amoxyclav in acute otitis media in children. J Antimicrob Chemother. 1990;26(Suppl A):29-36.
39. 39. Chamberlain JM, Boenning DA, Waisman Y, et al. Single-dose ceftriaxone versus 10 days of cefaclor for otitis media. Clin Pediatr. 1994;33:642-646.
40. 40. Ploussard JH. Evaluation of five days of cefaclor vs. ten days of amoxicillin therapy in acute otitis media. Curr Ther Res. 1984;36:641-645.
41. 41. Barnett ED, Teele DW, Klein JO, et al. Comparison of ceftriaxone and trimethoprim-sulfamethoxazole for acute otitis media. Pediatrics. 1997;99:23-28.
42. 42. Hendrickse WA, Kusmiesz H, Shelton S, Nelson JD. Five vs. ten days of therapy for acute otitis media. Pediatr Infect Dis J. 1988;7:14-23.
43. 43. Gooch WM, Blair E, Puopolo A, et al. Effectiveness of five days of therapy with cefuroxime axetil suspension for treatment of acute otitis media. Pediatr Infect Dis J. 1996;15:157-164.
44. 44. Pessey JJ, Gehanno P, Thoroddsen E, et al. Short-course therapy with cefuroxime axetil for acute otitis media: Results of a randomized multicenter comparison with amoxicillin/clavulanate. Pediatr Infect Dis J. 1999;18:854-859.
45. 45. Adam D. Five-day therapy with cefpodoxime versus ten-day treatment with cefaclor in infants with otitis media. Infection. 1995;23:398-400.
46. 46. Varsano I, Frydman M, Amir J, Alpert G. Single intramuscular dose of ceftriaxone as compared to 7-day amoxicillin therapy for acute otitis media in children. Chemotherapy. 1988;34(Suppl 1):39-46.
47. 47. Arguedas A, Loaiza C, Rodriguez F, et al. Comparative trial of 3 days of azithromycin versus 10 days of clarithromycin in the treatment of children with acute otitis media with effusion. J Chemother. 1997;9:44-50.
48. 48. Schaad UB. Multicentre evaluation of azithromycin in comparison with co-amoxiclav for the treatment of acute otitis media in children. J Antimicrob Chemother. 1993;31(Suppl E):81-88.
49. 49. Daniel RR. Comparison of azithromycin and co-amoxyclav in the treatment of otitis media in children. J Antimicrob Chemother. 1993;31(Suppl E):65-71.
50. 50. McLinn S. A multicenter, double blind comparison of azithromycin and amoxicillin/clavulanate for the treatment of acute otitis media in children. Pediatr Infect Dix J. 1996;15(Suppl):S20-S23.
51. 51. Aronovitz G. A multicenter, open label trial of azithromycin vs. amoxicillin/clavulanate for the management of acute otitis media in children. Pediatr Infect Dis J. 1996;15(9Suppl):S15-S19.
52. 52. Khurana CM. A multicenter, randomized, open label comparison of azithromycin and amoxicillin/clavulanate in acute otitis media among children attending day care or school. Pediatr Infect Dis J. 1996;15 (Suppl 9):S24-S29.
53. 53. Principi N. Multicenter comparative study of the efficacy and safety of azithromycin compared with amoxicillin/clavulanic acid in the treatment of paediatric patients with otitis media. Eur J Clin Microbiol Infect Dis. 1995;14:669-676.
54. 54. Ramet J, Belgian Paediatrician Clarithromycin Workgroup. Comparative safety and efficacy of clarithromycin and azithromycin suspensions in the short course treatment of children with acute otitis media. Clin Drug Invest. 1995;9:61-66.
55. 55. Kozyrski AL, Hildes-Ripstein GE, Longstaffe SE, et al. Treatment of acute otitis media with a shortened course of antibiotics: A meta-analysis. JAMA. 1998; 279:1736-1742.
56. 56. Cherry JD, Dudley JP. Sinusitis. In: Feigin RD, Cherry JD, eds. Textbook of Pediatric Infectious Diseases. 3rd ed. Philadelphia: WB Saunders Co; 1992:142-148.
57. 57. Gwaltney JM Jr. Sinusitis. In: Mandell GL, Douglas RG Jr, Bennett JE, eds. Principles and Practice if Infectious Diseases. 4th ed. Vol. 1. New York: Churchill Livingstone; 1995:585-590.
58. 58. Williams JW, Holleman DR Jr, Samsa GP, Simel DL. Randomized controlled trial of 3 vs. 20 days of trimethoprim/sulfamethoxazole for acute maxillary sinusitis. JAMA. 1995;273:1015-1021.
59. 59. Casiano RR. Azithromycin and amoxicillin in the treatment of acute maxillary sinusitis. Am J Med. 1991;91(Suppl 3A):27S-30S.
60. 60. Khong TK. Shortened therapies in acute sinusitis. Hosp Pract. 1996;31(Suppl 1): 11-13.
61. 61. Spector SL, Bernstein IL, Li JT, et al. Parameters for the diagnosis and management of sinusitis. J Allergy Clin Immunol. 1998;102(6 Pt 2):S107-S144.
62. 62. Froom J, Culpepper L, Jacobs M, et al. Antimicrobials for acute otitis media? A review from the International Primary Care Network. Br Med J. 1997;315:98-102.